Peregrine Pharmaceuticals, Inc. · Tustin, CA United States (NASDAQ: PPHM)
| 14272 Franklin Ave., Ste. 100 | Phone: 714-508-6000 |
| Tustin, CA | Fax: 714-838-5817 |
| 92780 | |
| United States | 
Map This Company |
Peregrine Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Peregrine Pharmaceuticals is spreading its wings and taking flight to attack and kill its prey: cancer and viral infections. Its clinical pipeline includes bavituximab being tested to treat pancreatic and liver cancer, as well as hepatitis C. Peregrine's other candidate, Cotara, attacks tumors from the inside out: the monoclonal antibody is loaded with radioisotopes and attaches itself to the DNA of dead and dying cells inside cancerous tissue, and then the radioisotopes bombard nearby tumor cells without harming healthy tissue. Cotara is in clinical trials for for the treatment of glioblastoma multiforme, a deadly brain cancer.
Peregrine Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: PPHM Headquarters |
|---|---|
| Fiscal Year-End | April |
| 2011 Employees | 156 |
Executives
20 executives listed for Peregrine Pharmaceuticals, Inc. 's Tustin, CA location.
| Chairman | Carlton Johnson | |
|---|---|---|
| President, CEO, and Director | Steven King | |
| CFO and Corporate Secretary | Paul Lytle |